Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.07 - Poster Session 1 - Surgery
- Type: Poster Session
- Track: Surgery
- Presentations: 48
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.07-047 - Could video-assisted thoracoscopic lobectomy plus mediastinal lymph node dissection be performed for non-small cell lung cancer in a low-volume hospital?
09:30 - 09:30 | Author(s): Y. Ding
- Abstract
Loading... -
+
P1.07-048 - Learning curve for video-assisted thoracoscopic Surgery lobectomy plus mediastinal lymph node dissection for non-small cell lung cancer: How many cases are needed to reach competence with guidance of consultant surgeon?
09:30 - 09:30 | Author(s): H. Wang
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-012 - Clinical observation from the treatment of icotinib for 196 cases with advanced non-small cell lung cancer
09:30 - 09:30 | Author(s): Q.A. Gu
- Abstract
Loading...
-
+
P1.12 - Poster Session 1 - NSCLC Early Stage
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 23
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.12-019 - Survival analysis of 106 female patients with completely resected lung adenocarcinoma in Shaanxi province
09:30 - 09:30 | Author(s): Y. Dai
- Abstract
Loading...
-
+
P3.06 - Poster Session 3 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 53
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.06-043 - Modulation of the cyclooxygenase pathway is associated with efficacy in a randomized phase II trial of erlotinib and celecoxib or placebo in advanced non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): M.C. Fishbein
- Abstract
Loading...
-
+
P3.11 - Poster Session 3 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.11-043 - Survival of patients with advanced lung adenocarcinoma before and after approved use of Gefitinib in China: a comparative clinical study in a single center
09:30 - 09:30 | Author(s): Y. Liu
- Abstract
Loading...
